Neurones Statistics
Total Valuation
Neurones has a market cap or net worth of EUR 1.05 billion. The enterprise value is 845.97 million.
Market Cap | 1.05B |
Enterprise Value | 845.97M |
Important Dates
The next estimated earnings date is Wednesday, September 11, 2024.
Earnings Date | Sep 11, 2024 |
Ex-Dividend Date | Jun 12, 2024 |
Share Statistics
Neurones has 24.27 million shares outstanding.
Shares Outstanding | 24.27M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 63.75% |
Owned by Institutions (%) | 15.88% |
Float | 8.80M |
Valuation Ratios
The trailing PE ratio is 21.23 and the forward PE ratio is 20.76.
PE Ratio | 21.23 |
Forward PE | 20.76 |
PS Ratio | 1.41 |
PB Ratio | 2.95 |
P/FCF Ratio | 19.34 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.34, with an EV/FCF ratio of 15.64.
EV / Earnings | 17.12 |
EV / Sales | 1.14 |
EV / EBITDA | 9.34 |
EV / EBIT | 11.33 |
EV / FCF | 15.64 |
Financial Position
The company has a current ratio of 2.38, with a Debt / Equity ratio of 10.78.
Current Ratio | 2.38 |
Quick Ratio | 2.33 |
Debt / Equity | 10.78 |
Debt / EBITDA | 0.49 |
Debt / FCF | 0.81 |
Interest Coverage | 52.09 |
Financial Efficiency
Return on equity (ROE) is 14.95% and return on invested capital (ROIC) is 10.82%.
Return on Equity (ROE) | 14.95% |
Return on Assets (ROA) | 7.23% |
Return on Capital (ROIC) | 10.82% |
Revenue Per Employee | 109,820 |
Profits Per Employee | 7,321 |
Employee Count | 6,749 |
Asset Turnover | 1.15 |
Inventory Turnover | 742.79 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +14.32% in the last 52 weeks. The beta is 0.59, so Neurones's price volatility has been lower than the market average.
Beta (5Y) | 0.59 |
52-Week Price Change | +14.32% |
50-Day Moving Average | 42.72 |
200-Day Moving Average | 43.94 |
Relative Strength Index (RSI) | 50.07 |
Average Volume (20 Days) | 3,847 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Neurones had revenue of EUR 741.18 million and earned 49.41 million in profits. Earnings per share was 2.03.
Revenue | 741.18M |
Gross Profit | 346.76M |
Operating Income | 74.69M |
Pretax Income | 80.77M |
Net Income | 49.41M |
EBITDA | 82.72M |
EBIT | 74.69M |
Earnings Per Share (EPS) | 2.03 |
Balance Sheet
The company has 297.76 million in cash and 43.98 million in debt, giving a net cash position of 253.78 million or 10.45 per share.
Cash & Cash Equivalents | 297.76M |
Total Debt | 43.98M |
Net Cash | 253.78M |
Net Cash Per Share | 10.45 |
Equity (Book Value) | 407.91M |
Book Value Per Share | 14.60 |
Working Capital | 316.89M |
Cash Flow
In the last 12 months, operating cash flow was 72.08 million and capital expenditures -17.98 million, giving a free cash flow of 54.09 million.
Operating Cash Flow | 72.08M |
Capital Expenditures | -17.98M |
Free Cash Flow | 54.09M |
FCF Per Share | 2.23 |
Margins
Gross margin is 46.78%, with operating and profit margins of 10.08% and 6.67%.
Gross Margin | 46.78% |
Operating Margin | 10.08% |
Pretax Margin | 10.90% |
Profit Margin | 6.67% |
EBITDA Margin | 11.16% |
EBIT Margin | 10.08% |
FCF Margin | 7.30% |
Dividends & Yields
This stock pays an annual dividend of 1.20, which amounts to a dividend yield of 2.78%.
Dividend Per Share | 1.20 |
Dividend Yield | 2.78% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 53.93% |
Buyback Yield | n/a |
Shareholder Yield | 2.78% |
Earnings Yield | 4.71% |
FCF Yield | 5.17% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |